Ameriprise Financial Inc Aerie Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.37 - $15.23 $8.3 Million - $19.8 Million	-1,302,754 Reduced 91.8%	116,422 $1.76 Million
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $4,311 - $7,978	871 Added 0.06%	1,419,176 $10.6 Million
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $3.44 Million - $5.98 Million	-610,482 Reduced 30.09%	1,418,305 $12.9 Million
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $2.86 Million - $5.43 Million	407,457 Added 25.13%	2,028,787 $14.2 Million
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $583,953 - $857,875	51,586 Added 3.29%	1,621,330 $18.5 Million
Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $324,242 - $405,730	-21,388 Reduced 1.34%	1,569,744 $25.1 Million
Q1 2021 May 17, 2021	BUY	$13.12 - $20.9 $2.93 Million - $4.67 Million	223,648 Added 16.35%	1,591,132 $28.4 Million
Q4 2020 Feb 12, 2021	BUY	$9.12 - $14.49 $2.33 Million - $3.7 Million	255,354 Added 22.96%	1,367,484 $18.5 Million
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $2.89 Million - $3.99 Million	276,055 Added 33.02%	1,112,130 $13.1 Million
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $3.96 Million - $5.32 Million	-329,946 Reduced 28.3%	836,075 $12.3 Million
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $640,366 - $1.38 Million	54,085 Added 4.86%	1,166,021 $15.7 Million
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $2.56 Million - $3.63 Million	144,698 Added 14.96%	1,111,936 $26.9 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $8.45 Million - $12.8 Million	458,876 Added 90.27%	967,238 $18.6 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $3.17 Million - $5.27 Million	109,298 Added 27.39%	508,362 $15 Million
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $465,150 - $630,744	-12,807 Reduced 3.11%	399,064 $19 Million
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $2.58 Million - $4.69 Million	78,095 Added 23.4%	411,871 $14.9 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $740,113 - $974,075	13,181 Added 4.11%	333,776 $20.3 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $1.95 Million - $2.87 Million	40,717 Added 14.55%	320,595 $21.6 Million
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $794,052 - $946,964	-15,524 Reduced 5.26%	279,878 $15.2 Million
Q4 2017 Feb 12, 2018	BUY	$50.85 - $65.1 $280,946 - $359,677	5,525 Added 1.91%	295,402 $17.7 Million
Q3 2017 Nov 07, 2017	BUY	$48.6 - $60.1 $14.1 Million - $17.4 Million	289,877	289,877 $14.1 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account